miR ‐20a‐5p regulated SMAD6 to inhibit chondrogenesis of hDPSCs
Oral Diseases · 2023-11 · 29 (8) · 3433-3446
DOI: 10.1111/odi.14331 ↗At a glance
Journal article in Oral Diseases, published online on 2022-08-16. Written by Xuefeng Pan and 5 co-authors. Institution: State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, …. Major MEDLINE topics: MicroRNAs. Cited 6 times so far (Crossref); 55 references. Funded by: China Postdoctoral Science Foundation, National Natural Science Foundation of China, Research and Development Foundation of West China Hospital of Stomatology.
Abstract (original language)
Objectives Chondrogenic differentiation of human dental pulp stem cells (hDPSCs) is highly promising for cartilage repair. The specific mechanism, however, still needs to be explicated. Materials and Methods In this study, we isolated hDPSCs and transfected cells with lentiviruses containing an over‐expression, knock‐down, or negative control of miR‐20a‐5p. Three‐D pellet cultures of hDPSCs were used for the chondrogenic induction. Following the pellet culture period, chondrogenesis was assessed by histological and immunohistochemical analysis and expression of chondrogenic‐related genes. Dual‐luciferase report assay was performed to determine potential targeted genes of miR‐20a‐5p, and the phosphorylation levels of P65 and IκBα were explored. Animal experiments were performed to determine the effect of miR‐20a‐5p on cartilage regeneration. Results miR‐20a‐5p was showed to repress the expression of SMAD6 to inhibit the chondrogenic differentiation of hDPSCs. Accordingly, the knock‐down of miR‐20a‐5p promoted cartilage regeneration in the osteochondral defects of rats. Mechanically, it is indicated that NF‐κB signaling is the potential down‐stream network of miR‐20a‐5p/Smad6 crosstalk during chondrogenic differentiation. Conclusions miR‐20a‐5p could target SMAD6 to activate NF‐κB signaling pathway, and thus inhibit chondrogenesis of hDPSCs, which provided promising therapeutic target for cartilage defects clinically.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
- Department of Orthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
- Department of Temporomandibular Joint, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
- Zhejiang International Scientific and Technological Cooperative Base of Biomedical Materials and Technology, Zhejiang Engineering Research Center for Biomedical Materials, Cixi Institute of Biomedical Engineering, Ningb…
ORCID profiles: Xinqi Huang, Zhihe Zhao, Xiao Cen
Funding
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Research and Development Foundation of West China Hospital of Stomatology
- Research Funding from West China School/Hospital of Stomatology Sichuan University
- Sichuan Science and Technology Program
Cite
APA
Pan, X., Huang, X., Zhang, B., Pei, F., Zhao, Z., & Cen, X. (2023). miR ‐20a‐5p regulated SMAD6 to inhibit chondrogenesis of hDPSCs. Oral Diseases, 29(8), 3433-3446. https://doi.org/10.1111/odi.14331
Vancouver
Pan X, Huang X, Zhang B, Pei F, Zhao Z, Cen X. miR ‐20a‐5p regulated SMAD6 to inhibit chondrogenesis of hDPSCs. Oral Diseases. 2023;29(8):3433-3446. doi:10.1111/odi.14331
BibTeX
@article{Pan2023,
author = {Pan, Xuefeng and Huang, Xinqi and Zhang, Bo and Pei, Fang and Zhao, Zhihe and Cen, Xiao},
title = {miR ‐20a‐5p regulated SMAD6 to inhibit chondrogenesis of hDPSCs},
journal = {Oral Diseases},
year = {2023},
volume = {29},
number = {8},
pages = {3433--3446},
doi = {10.1111/odi.14331}
}
EUVIMED